Organic electroluminescent materials and devices

US9493698B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9493698-B2
Application numberUS-201213584483-A
CountryUS
Kind codeB2
Filing dateAug 13, 2012
Priority dateAug 31, 2011
Publication dateNov 15, 2016
Grant dateNov 15, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Novel phosphorescent tetradentate platinum (II) compounds are provided. The compounds contain an isoimidazole moiety, optionally further substituted with a twisted aryl. These compounds may be advantageously used in OLEDs.

First claim

Opening claim text (preview).

The invention claimed is: 1. A compound having the formula: wherein A, B, and C are each independently a 5- or 6-membered carbocyclic or heterocyclic ring; wherein L 1 and L 3 are independently selected from the group consisting of a single bond, BR, NR, PR, O, S, Se, C═O, S═O, SO 2 , CRR′, SiRR′, and GeRR′; wherein L 2 is selected from the group consisting of BR, NR, PR, O, S, Se, C═O, S═O, SO 2 , CRR′, SiRR′, and GeRR′; wherein n 1 is 0 or 1; wherein n 2 is 0 or 1; wherein n 1 +n 2 is at least equal to 1; wherein Z 1 and Z 2 are independently a nitrogen atom or a carbon atom; wherein R 1 , R 2 , R 3 , and R 4 may represent mono-, di-, tri-, or tetra-substitutions; wherein R, R′, R 1 , R 2 , R 3 , R 4 , and R 5 are independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein R 1 is optionally fused to A; wherein R 3 is optionally fused to B; wherein R 4 is optionally fused to C; wherein R 3 and R 4 are optionally joined to form into a ring; wherein R 3 and L 2 are optionally joined to form into a ring; wherein R 4 and L 2 are optionally joined to form into a ring; and wherein at least one of the following (i)-(vi) is true: (i) n 1 =0 and n 2 =1; (ii) wherein R 5 is wherein R′ 1 and R′ 2 are independently selected from the group consisting of halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, partially or fully deuterated variations thereof, and combinations thereof; wherein D is 5-membered or 6-membered carbocyclic or heterocyclic ring that is optionally further substituted with R′ 3 ; and wherein R′ 3 is selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; (iii) wherein the compound has the structure of Formula IIA, (iv) wherein the compound has the structure of Formula IIIA, (v) wherein the compound has the structure of Formula VIA, and (vi) wherein the compound has the structure of Formula VIIA, 2. The compound of claim 1 , wherein R 5 is a 2,6-disubstituted aryl. 3. The compound of claim 1 , wherein R 5 is wherein R′ 1 and R′ 2 are independently selected from the group consisting of halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein D is 5-membered or 6-membered carbocyclic or heterocyclic ring that is optionally further substituted with R′ 3 ; and wherein R′ 3 is selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof. 4. The compound of claim 3 , wherein each of R′ 1 and R′ 2 is an alkyl. 5. The compound of claim 3 , wherein each of R′ 1 and R′ 2 is an alkyl containing at least 2 carbons. 6. The compound of claim 3 , wherein each of R′ 1 and R′ 2 is an aryl. 7. The compound of claim 3 , wherein the compound has the formula: 8. The compound of claim 3 , wherein the compound has the formula: 9. The compound of claim 3 , wherein the compound has the formula: 10. The compound of claim 3 , wherein the compound has the formula: 11. The compound of claim 1 , wherein L 1 or L 3 is selected from the group consisting of O, S, CH 2 , CR′ 2 , NR′, SiR′ 2 or BR′; and wherein R′ is alkyl or aryl. 12. The compound of claim 1 , wherein L 2 is selected from the group consisting of O, S, CH 2 , CR′ 2 , NR′, and SiR′ 2 ; wherein R′ is alkyl or aryl; and wherein R′ is optionally bonded to B or C. 13. The compound of claim 1 , wherein R 1 , R 2 , R 3 and R 4 are each independently selected from the group consisting of hydrogen, deuterium, alkyl, aryl, cyclic alkyl, branched alkyl, heteroaryl, and fused aryl. 14. The compound of claim 1 , wherein the compound is selected from the group consisting of:

Assignees

Inventors

Classifications

  • of the platinum group, i.e. Os, Ir, Pt, Ru, Rh or Pd · CPC title

  • characterised by the nature or concentration of the activator · CPC title

  • containing two nitrogen atoms as heteroatoms · CPC title

  • C09K11/06Primary

    containing organic luminescent materials · CPC title

  • Platinum compounds · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9493698B2 cover?
Novel phosphorescent tetradentate platinum (II) compounds are provided. The compounds contain an isoimidazole moiety, optionally further substituted with a twisted aryl. These compounds may be advantageously used in OLEDs.
Who is the assignee on this patent?
Beers Scott, Xia Chuanjun, Brooks Jason, and 2 more
What technology area does this patent fall under?
Primary CPC classification C09K11/06. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).